IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q4 2022 Holdings

Filed 2023-02-14 | 3 holdings | $84.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$44.2M3,846,15452.0%
Biohaven LTD(BHVN)COMG1110E107$40.8M2,936,50748.0%
Viracta Therapeutics IncCOM92765F108$5.4K3,7000.0%